Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI

Exclusion Criteria

• •Must not be currently hospitalized or have been hospitalized within the last year for a psychiatric illness
• •Must not be diagnosed with a neurodegenerative disease (e.g., Alzheimer's disease, Parkinson's disease)
• •Must not have any Central Nervous System disease (e.g., movement disorder, multiple sclerosis)
• •Subjects could have had a TIA (transient ischemic attack) or stroke in the past if the TIA or stroke was greater than 1 year ago and the subject does not have any remaining symptoms
• •Must not be scheduled to receive concurrent radiation treatment while receiving chemotherapy.
• •Must not be colorblind
• •Must not be currently hospitalized or have been hospitalized within the last year for a psychiatric illness
• •Must not be diagnosed with a neurodegenerative disease (e.g. Alzheimer's disease, Parkinson's disease)
• •Must not have Central Nervous System disease (e.g., movement disorder, multiple sclerosis)
• •Subjects could have had a TIA (transient ischemic attack) or stroke in the past if the TIA or stroke was greater than 1 year ago and the subject does not have any remaining symptoms
• •Must not have been diagnosed with cancer or previously have received chemotherapy
• •Must not be colorblind
• •For optional sub-study: MR safety assessed via Rochester Center for Brain Imaging Magnetic Resonance (MR) Safety Screening Form to confirm eligibility to participate